Impact of Posttreatment SPECT/CT on Patient Management During (177)Lu-PSMA-617 Radiopharmaceutical Therapy. Yadav S, Lowery B, Tuchayi AM, Jiang F, et al. J Nucl Med 2024 Aug 8:jnumed.124.267955. doi: 10.2967/jnumed.124.267955.

Read + Share

Amedeo Smart

Independent Medical Education

Yadav S, Lowery B, Tuchayi AM, Jiang F, et al. Impact of Posttreatment SPECT/CT on Patient Management During (177)Lu-PSMA-617 Radiopharmaceutical Therapy. J Nucl Med 2024 Aug 8:jnumed.124.267955. doi: 10.2967/jnumed.124.267955.
PMID: 39117452